How to Buy Guardant Health Stock
Guardant Health Inc
Guardant Health, Inc. , established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally.
Guardant Health stock last closed at $168.48, up 6.92% from the previous day, and has increased 234.35% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 2.06 percentage points. Guardant Health stock is currently +216.16% from its 52-week low of $53.29, and -4.59% from its 52-week high of $176.58.
As of Aug 7, 2026, there are 134.2M shares of GH outstanding. The market capitalization of GH is $22.61B. In the past 24 hours, 2.16M GH shares were traded.
How to Buy Guardant Health Stock
Wondering how to invest in Guardant Health stock? Here's how.
- Decide where to buy Guardant Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Guardant Health stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your method of payment and add your info.
- Analyze Guardant Health stock: The Guardant Health ticker symbol is GH. Is Guardant Health stock a good investment? Should you buy shares of GH? How do GH's underlying business fundamentals look? Do top analysts think Guardant Health is a good buy? Why has GH's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if GH is a good stock to buy).
- Execute your GH trade: Decide if you will purchase GH shares at the current market price or use a limit order to purchase GH stock at a given price.
- Keep an eye on your GH position: Create a watchlist to monitor your investment in Guardant Health shares.
Step 1: Decide where to buy Guardant Health stock
You will need a brokerage account to access the NASDAQ market and buy GH stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you are able to invest in GH stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best stock trading app, you need to deposit funds:
Check out the video below for more details depositing funds into your investment account.
Step 4: Analyze Guardant Health stock
After you have decided on the best place to buy Guardant Health stock, it's absolutely critical to analyze their stock prior to buying, so you actually wrap your head around the risk and opportunity.
Guardant Health quick stats
GH Overview
WallStreetZen was built to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on GH's stock page.
Is GH stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge GH's intrinsic value.
You can access additional valuation research on GH's stock here.
GH Financial Overview
Passed Health Checks:
- GH has cash burn of 240724000. It has sufficient cash and short-term investments to cover this for at least one year.
- GH has $1.17B in cash and short term investments. This is enough to cover its annual cash burn of $240.72M.
- There are more short-term assets than short-term liabilities on the GH balance sheet.
Failed Health Checks:
- Total GH debt is still negative.
- There are more long-term liabilities than short-term assets on the GH balance sheet.
- GH profit margin has gone up by 0.12 percentage points in the past year, but the company is still unprofitable.
- GH debt to equity ratio of -9.58 is negative.
Do Wall Street analysts think it's a good time to buy Guardant Health stock
Out of 22 Equities analysts who research GH, the consensus analyst rating on Guardant Health is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest GH Analyst Ratings
Anthony Petrone, a top 6% analyst from Mizuho maintains GH with a buy rating and raises their GH price target from $175.00 to $200.00, on Jul 31, 2026.
Casey Woodring, a top 22% analyst from JP Morgan maintains GH with a strong buy rating and raises their GH price target from $185.00 to $195.00, on Jul 31, 2026.
Dan Brennan, a top 4% analyst from TD Cowen maintains GH with a strong buy rating and raises their GH price target from $200.00 to $210.00, on Jul 31, 2026.
Luke Sergott, a top 8% analyst from Barclays maintains GH with a strong buy rating and raises their GH price target from $150.00 to $200.00, on Jul 31, 2026.
Mark Massaro, a top 1% analyst from BTIG maintains GH with a strong buy rating and raises their GH price target from $190.00 to $195.00, on Jul 31, 2026.
BTIG's Mark Massaro raised their price target on Guardant Health (NASDAQ: GH) by 2.6% from $190 to $195 on 2026/07/31. The analyst maintained their Strong Buy rating on the stock.
Guardant Health reported its Q2 2026 earnings.
Raising their price target, Massaro summarized that the quarter delivered another strong beat and raise.
The analyst detailed that they were particularly impressed by the quarter's strong 63% Y/Y core oncology volume growth and record 22k sequential growth in its Guardant Health's nascent Shield screening business.
Earnings Report
For Q2 2026, Guardant Health reported:
- EPS of $(0.42), which missed the Zacks Consensus Estimate of $(0.40) but beat Q2 2025's $(0.44).
- Revenue of $334.98M, which beat the Zacks Consensus Estimate by 6.01% and Q2 2025's $232.09M.
For FY 2026, management guided:
- Revenue of $1.34B to $1.36B, up from the prior $1.3B to $1.32B.
Co-CEO Helmy Eltoukhy commented: “Our second-quarter performance reflected broad-based momentum across the Guardant portfolio, with revenue increasing 44% year over year.
“Growth was fueled by strong oncology volume, with acceleration across every product.
"The landmark FDA approval of Guardant360 Liquid CDx further strengthens our portfolio and positions us to drive sustained growth in the years ahead.”
You can dive deeper into what analysts are forecasting on the Guardant Health stock forecast page.
GH Momentum
GH Performance Numbers
Last year, GH revenue was $1.18B. In the past five year, GH's revenue has gone up by 29.6% per year. This was faster than the Diagnostics & Research industry average of 7.23%.
Find out more about GH's earnings and revenue performance here.
Who is buying/selling GH?
Over the past year, insiders at GH have sold more shares than they have bought.
Medina Manuel Hidalgo, Director of GH, was the latest GH insider to buy. They bought $30,922.50 worth of GH stock on Aug 5, 2026.
Research more about who owns GH stock here.
Does GH provide a stable income stream?
No, Guardant Health doesn't provide an income stream by paying out dividends.
What others are saying about GH
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your GH trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and your broker will place the order.
If you need additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your GH position
Now that you own some GH shares, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to track your GH stock.
GH Feed
How to Buy Stock in Guardant Health
To summarize, here are the 6 steps you need to take to buy Guardant Health stock right now:
- Decide where to buy Guardant Health stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Analyze Guardant Health stock
- Execute your GH trade
- Keep an eye on your GH position
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get updates on your investment in Guardant Health, add GH to your watchlist by clicking the button below.
Other "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.